Chasing epidemics from one crisis to the next is not a winning strategy, especially with outbreak-prone diseases like Ebola, cholera and measles. For these diseases the world must have stronger systems in place before emergencies spiral. Gavi CEO Dr @SaniaNishtar on why resilience must be built into global health reform: bit.ly/4xA8xOm

Repeated global health emergencies have exposed the fact that, as an international community, we do not yet have an effective and sustainable model to build resilience in the face of global health threats. In my latest op-ed I highlight the urgent need for coordinated, sustainable global health reform, and why the European Commission’s adoption of the Global Health Resilience Initiative is an important milestone towards building global health resilience: bit.ly/4xA8xOm @EU_Commission #TeamEurope

For parents living in remote areas, a localised outbreak of a preventable disease brings constant worry. Here's how mobile teams in the DRC are overcoming logistical hurdles to bring routine vaccines straight to villages that have previously missed out: bit.ly/4ei2vJl

Are children getting their vaccines too late? While late vaccination is always better than missing out entirely, timing is everything. New research shows that widespread delays across low- and middle-income countries are leaving infants unprotected during their most critical, early weeks of life. The full story: bit.ly/4vFJwzt

Data from Togo shows that irregular vaccine uptake during pregnancy often predicts lower immunisation for infants after birth. Here’s a closer look at the hidden barriers that keep expectant mothers away from clinics, and what’s being done to keep women connected to care: bit.ly/4xgUPiU

As health teams in Benin prepare to launch a new polio immunisation drive, they have a powerful voice helping them reach parents: pop singer and polio survivor Miss Espoir. Her story: bit.ly/4vAJQPN

Could one vaccine protect against both Lassa fever and rabies? An experimental vaccine against Lassa virus and rabies has shown promise in its first human trial. The story: bit.ly/4gbSM9P

New TB vaccines are on the horizon. In Zambia, scientists are already figuring out how best to deploy it. Here’s what you need to know: bit.ly/4vzxCXG

"It seemed to prove that the messenger mattered quite as much as the message." In Chiredzi, Zimbabwe, women lined up by the hundreds for life-saving cervical cancer screenings thanks to a joint campaign by the country's largest sugar producer and the Ministry of Health. Here’s how the initiative is helping overcome barriers to preventative healthcare: bit.ly/4ohCXk2

What does El Niño have to do with infectious diseases? A lot. From flooding that accelerates malaria to droughts that trigger cholera, extreme weather creates the perfect conditions for outbreaks. Here’s how experts are getting ahead of the threat: bit.ly/3SswAOP

Most children receive vaccines weeks or months later than recommended, especially in low- and middle-income countries. A child who receives a vaccine late is still better protected than a child who never receives it. Yet even a delay of a few weeks can leave them vulnerable during periods when the risk of serious disease is highest. Here's the latest evidence on why vaccine timing matters: bit.ly/4vFJwzt

With an active Bundibugyo Ebola outbreak in the DRC and Uganda, researchers are working rapidly to move new vaccine candidates into trials. Here’s why existing Ebola vaccines aren’t approved to fight the current Bundibugyo outbreak, and the complex scientific and economic race to build a new one: bit.ly/3SxOeAM via @ConversationUK

Researchers at the University of Cambridge have successfully used AI to scan sarbecoviruses (the viral family including SARS and COVID), looking for shared genetic features that evolution has left largely untouched. Those shared features became the basis of a new vaccine candidate currently in testing, designed to work against the whole viral family rather than just a single strain. The full science explainer: bit.ly/4alXIVS via @ConversationUK

Reaching unimmunised children in hard-to-access areas is a constant challenge for health workers, especially in countries with constrained resources. In the DRC, community health workers are mapping remote villages and traveling long distances to ensure zero-dose children are no longer left behind. And for parents on the ground, the arrival of these routine mobile clinics brings immense relief in the face of preventable outbreaks like measles. The full story, on our VaccinesWork platform: bit.ly/4ei2vJl

Inspiring to meet with community leaders and elders to thank them for championing immunisation. Their trusted voices are key to overcoming misinformation and strengthening confidence in vaccines.

Is there a vaccine for Ebola? The answer is yes... and no. Ebola isn’t just a single virus, and the latest Bundibugyo outbreak is spreading without an approved vaccine or treatment. Let's break down the current state of Ebola vaccines, and what scientists are doing to help close the gap. ( read more here: gavi.org/vaccineswork/market…)

Outbreaks are rarely contained by vaccines alone. Here’s how communication, community engagement and trust all shape the impact vaccines can have: bit.ly/4oemtZQ via @ConversationUK

The Bundibugyo outbreak currently spreading in DRC is hugely concerning. That’s why @Gavi and @CEPIvaccines have teamed up on a new strategy that will help buy ‘speed, capacity and access’ for a future vaccine. The full story: bit.ly/4g1nWRe

In parts of West Africa, Lassa fever and rabies frequently threaten the same communities. In areas with limited healthcare access, every separate vaccine injection is a challenge to deliver. A new combination vaccine candidate for rabies and Lassa fever aims to solve that problem by bundling protection into a single vaccine. If approved, it would be a big step towards streamlining delivery and protecting vulnerable communities against two deadly viral threats at once. Early results from the first human trials show promising safety profiles and immune responses. The latest: bit.ly/4gbSM9P

“Pandemic preparedness must be considered as a true global public good.” At the United Nations consultation on pandemic preparedness, Gavi’s Pascal Barollier outlined five key priorities to strengthen the world's ability to respond to future pandemics. Our response should be rapid, equitable and proactive: bit.ly/4g5ycrx